on Viemed Healthcare, Inc. (NASDAQ:VMD)
Viemed Healthcare Reports Record Q2 2026 Financial Results
Viemed Healthcare, Inc., a national provider of technology-enabled healthcare solutions, announced its financial results for the second quarter of 2026. The company posted net revenues of $78.1 million, marking a 23.9% increase from the previous year and setting a company record. However, adjusted EBITDA showed a 4.0% decline due to a non-recurring gain in 2025.
Despite this, the company maintained strong operational performance, with net income totaling $2.8 million. Viemed also reported free cash flow of $8.6 million and a cash balance of $10.7 million at the quarter's end. For 2026, the company has adjusted its revenue expectations to between $314 million and $320 million.
The company emphasizes growth across its platforms, including a record increase in ventilator and PAP therapy patients. Viemed's CEO, Casey Hoyt, highlighted the company's momentum, citing solid balance sheets and cash generation as key strengths.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Viemed Healthcare, Inc. news